For the last three decades myocardial perfusion imaging (MPI) with single photon emission computed tomography (SPECT) has been an excellent tool for guiding clinicians in the management of patients with known or suspected coronary artery disease (CAD). However, despite its documented high diagnostic accuracy 1 myocardial perfusion SPECT may fail to detect the true extent of coronary atherosclerosis and thus underestimate the coronary risk in individual patients.
2In fact, large observational studies have shown that 43% 3 of patients suffering a myocardial infarction and 31% 4 of patients dying from a cardiac cause had a normal or only mildly abnormal prior perfusion scan. A possible explanation for these shortcomings is inherent in the nature of the technique. MPI evaluates the hemodynamic relevance of coronary stenoses and therefore can only detect obstructive coronary lesions. However, approximately half of patients with normal SPECT perfusion have subclinical CAD on coronary CT angiography (CTA).5 Histopathological correlation studies demonstrate that almost 70% of coronary occlusions (leading to myocardial infarction) result from thrombosis of lesions with a stenosis of less than 50% before infarction.6 This explains to some extent whydespite evidence of normal myocardial perfusionpatients with subclinical CAD are at higher risk of coronary events, and underlines the importance of assessing the full (i.e., subclinical) extent of CAD to guide therapeutic decisions. Recent years have witnessed tremendous technological advances in coronary multislice CTA paralleled by an increased use of this technology in clinical practice. Given its high spatial resolution, its noninvasive nature, its relative ease of use, and its complementary value to MPI, CTA has been used as an ideal partner modality for hybrid (or multimodality) imaging with nuclear techniques. Additionally, the increased availability of dedicated fusion software packages for three-dimensional coregistration of CTA and MPI have facilitated the use of hybrid imaging in clinical practice. 8,9 The feasibility and clinical robustness of noninvasive hybrid imaging was first documented by Namdar and coworkers in a clinical study involving fusion of 13 N-ammonia positron emission tomography (PET) with 4-slice CTA in 25 patients with CAD. 10 The hybrid PET/CTA images allowed to identify flow-limiting coronary lesions which required a revascularization procedure (as defined by invasive coronary angiography and PET) with a sensitivity, specificity, positive, and negative predictive value of 90%, 98%, 82%, and 99%, respectively. These encouraging results were confirmed by a similar study with SPECT/CTA showing that the hybrid approach resulted in a significant improvement in specificity (from 63% to 95%) and positive predictive value (from 31% to 77%) compared to CTA alone for detecting flow-limiting coronary stenoses.11 Santana and colleagues showed significantly higher diagnostic performance for fused SPECT/CT imaging compared to SPECT alone (P \ 0.001) and to th...